Literature DB >> 18614921

Chronic kidney disease prevalence and risk factors among HIV-infected patients.

María L Sorlí, Ana Guelar, Milagro Montero, Alicia González, Eva Rodriguez, Hernando Knobel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18614921     DOI： 10.1097/QAI.0b013e31817bbecb

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  15 in total

1.  Risk factors for kidney disease among HIV-1 positive persons in the methadone program.

Authors:  Bartłomiej Matłosz; Ewa Pietraszkiewicz; Ewa Firląg-Burkacka; Ewa Grycner; Andrzej Horban; Justyna D Kowalska
Journal:  Clin Exp Nephrol       Date:  2018-09-14       Impact factor: 2.801

2.  Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Gregory M Lucas; Michael J Ross; Peter G Stock; Michael G Shlipak; Christina M Wyatt; Samir K Gupta; Mohamed G Atta; Kara K Wools-Kaloustian; Paul A Pham; Leslie A Bruggeman; Jeffrey L Lennox; Patricio E Ray; Robert C Kalayjian
Journal:  Clin Infect Dis       Date:  2014-09-17       Impact factor: 9.079

3.  Kidney Disease in HIV-Infected Persons.

Authors:  Robert C Kalayjian
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

4.  Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study.

Authors:  Johann Cailhol; Béatrice Nkurunziza; Hassan Izzedine; Emmanuel Nindagiye; Laurence Munyana; Evelyne Baramperanye; Janvière Nzorijana; Désiré Sakubu; Théodore Niyongabo; Olivier Bouchaud
Journal:  BMC Nephrol       Date:  2011-08-24       Impact factor: 2.388

5.  Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil.

Authors:  Andréia M Menezes; Jorge Torelly; Lúcia Real; Mônica Bay; Julia Poeta; Eduardo Sprinz
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

6.  Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.

Authors:  Alessandra Bandera; Andrea Gori; Francesca Sabbatini; Giordano Madeddu; Stefano Bonora; Raffaella Libertone; Claudio Mastroianni; Paolo Bonfanti; Antonella d'Arminio Monforte; Alessandro Cozzi-Lepri
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

7.  Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database.

Authors:  Francis Kalemeera; Assegid T Mengistu; Johannes Gaeseb
Journal:  J Pharm Policy Pract       Date:  2015-04-20

8.  Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012.

Authors:  Philippe Morlat; Alexandre Vivot; Marie-Anne Vandenhende; Frédéric-Antoine Dauchy; Julien Asselineau; Edouard Déti; Yann Gerard; Estibaliz Lazaro; Pierre Duffau; Didier Neau; Fabrice Bonnet; Geneviève Chêne
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

9.  Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.

Authors:  Amanda Mocroft; Jacqueline Neuhaus; Lars Peters; Lene Ryom; Markus Bickel; Daniel Grint; Janak Koirala; Aleksandra Szymczak; Jens Lundgren; Michael J Ross; Christina M Wyatt
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

Review 10.  Update on current management of chronic kidney disease in patients with HIV infection.

Authors:  Nina E Diana; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.